Drug
Long Acting Reversible Contraception
Long Acting Reversible Contraception: highest development phase Post-Market, developed by Bayer. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Bayer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Long Acting Reversible Contraception (LARC) NCT02735551 | Post-Market | Contraception |
Latest
No recent events.
Follow Long Acting Reversible Contraception on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.